Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 4 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Association between Intraoperative Blood Loss and Postoperative Outcomes in Colorectal Perforation: A Retrospective Observational Study in Japan.
    Ikutaro Yamashita, Shokei Matsumoto, Masayuki Shimizu
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMCDOAJ
  2. Clinical Impact of Prognostic Immune and Nutritional Index on Short- and Long-term Outcomes of Older Patients with Colorectal Cancer.
    Daiki Matsubara, Miki Tanaka, Atsuhito Ando +5
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  3. Subserosal Indocyanine Green Mapping in Colorectal Surgery Using an Adjustable Laparoscopic Injection Needle.
    Jun Nagata, Hiroto Sannomiya, Kensuke Nitta +8
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  4. Lymphocyte-to-monocyte Ratio Predicts Small-bowel Obstruction after Laparoscopic Colon Cancer Surgery.
    Koki Tamai, Mitsuyoshi Tei, Naoto Tsujimura +8
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  5. Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Koyo Kido, Akiko Chino, Takashi Akiyoshi +9
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  6. Resilience and Well-Being Levels in Patients Diagnosed with Cancer and Influencing Factors
    Merve Atalay, Saliha Hallaç
    Psikiyatride Güncel YaklaşımlarPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  7. Synergistic strategies of tumor ablation and immunotherapy in hepatocellular carcinoma: mechanisms, clinical translation, and perspectives
    Ying Liu, Linke Bian, Hongye Wang +3
    Holistic Integrative OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  8. Erasing the invisible: targeting persister cells to cure minimal residual disease
    Yu Wang, Zijian Shi, Fangquan Xu +8
    Holistic Integrative OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  9. Manufacturer-chart versus measured ablation volumes after microwave ablation of hepatocellular carcinoma in cirrhotic livers: a retrospective cohort study
    Riccardo Muglia, Kessy Djonis Martins de Mattos, Francesco Saverio Carbone +5
    CVIR OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  10. New biological classification of tumors based on integrative medicine and its prospective clinical application
    Shi Zheng, Yuanyuan Lu, Daiming Fan
    Holistic Integrative OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  11. SPP1⁺ macrophage-derived WNT5A contributes to MMP11⁺ myCAF-mediated matrix remodeling and immunotherapy resistance in lung adenocarcinoma
    Menglei Wang, Pengcheng Zhang, Xuefeng Li +3
    Journal of Translational MedicinePeer-reviewedCC BYFull textOncologyDOAJ
  12. The study of Relationship between Dysregulation of RP11-446E9, HOTAIR, and P21 Long non-coding RNA and Acute Lymphocytic Leukemia Patients
    Nihayat Hussein Hamad, Zirak Faqe Ahmed Abdulrahman
    Tikrit Journal of Pure SciencePeer-reviewedCC BYFull textOncologyDOAJ
  13. Impact of SARS-CoV-2 vaccination on cancer trends: a nationwide interrupted time series study
    Yewon Na, Munkhzul Radnaabaatar, Jaehun Jung
    Biomarker ResearchPeer-reviewedCC BYFull textOncologyDOAJ
  14. Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation
    Peng Huang, WenLin Wu, Yu Min +5
    Experimental Hematology & OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  15. Diffusion-weighted magnetic resonance imaging and immunohistochemistry in Epstein-Barr virus-positive diffuse large B-cell lymphoma of the maxilla: a rare case report
    Yoriaki Kanri, Yuko Watarai, Ryo Mizuhashi +2
    The Egyptian Journal of OtolaryngologyPeer-reviewedCC BYFull textOncologyDOAJ
  16. Maternal and neonatal outcomes of pregnancy-associated cancer by cancer type
    Wuraola Ruth Awosan, David Sokoyebomi Oluwafemi Abafi, Naa Komley Commey +4
    Discover Public HealthPeer-reviewedCC BYFull textOncologyDOAJ
  17. Listeriolysin O, alone and in combination with Cisplatin and Carfilzomib, modulates MDR1, MRP1, and BCRP expression in Cisplatin-sensitive and -resistant ovarian cancer cells
    Navid Ghasemzadeh, Javad Zavar Reza, Amir Hossein Fatehi Marj +3
    Journal of Preventive and Complementary MedicinePeer-reviewedCC BY-NCFull textOncologyDOAJ
  18. Impact of Metronomic Capecitabine after Standard Treatment in Non Metastatic Triple Negative Breast Cancer: A Retrospective Study
    Alaa Hegazy, Shaimaa Abdelhai, Abdelmotaleb Ibrahim +2
    Zagazig University Medical JournalPeer-reviewedCC BY-NCFull textOncologyDOAJ
  19. MSCAnet: A multi-scale cross-attention network for chromosomal instability prediction in breast cancer whole-slide images
    Ying Wang, Yue Hu, Liangliang Liu
    Intelligent OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  20. Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma
    D. Alizadeh, R. A. Wong, M. S. Maker +15
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  21. A Collagen-Based 3D Microtissue Platform Preserves Structural, Molecular, and Therapeutic Heterogeneity in Ovarian Cancer
    P. Soori, M. Javan, L. Winstone +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  22. DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy
    Timothy B. Branigan, Roshen Alharthi, Bose S. Kochupurakkal +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  23. Cancer cells acquire cysteine directly from a reduced tumor microenvironment
    Feroza K. Choudhury, Basma A. Yasseen, Paloma González-Sánchez +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  24. Quantifying epigenetic reprogramming and cellular plasticity in preneoplastic lesions reveals dedifferentiation as a key precancer hallmark
    A. Teschendorff, J. K. Tham
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  25. Matrix stiffness shapes immunometabolic states and response to PD-1 blockade in gastric cancer
    Q. Shu, J. Wu, Z. Wang +17
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv